A Letter From Scot GOV
Published: 17/12/21

As we approach the festive period, we wanted to thank pharmacy teams for your hard work in the recent period of high demand.
To the Community Pharmacy Network from The Scottish Government
As we approach the festive period, we wanted to thank pharmacy teams for your hard work in the recent period of high demand. The community pharmacy network is a vital part of our public health response to COVID-19 and that is reflected in the impact the network has had on access to LFD test kits since the introduction of the Pharmacy Collect arrangements in June of this year. Community pharmacies in Scotland have distributed over 1.3 million packs – which is almost 10 million tests – helping to keep us all safe during this time.
Community pharmacies remain one of the quickest and most accessible routes to access test kits and the Scottish Government will continue to promote other routes that are available, including online. To support this, the Scottish Government have worked with the UK Government to double the capacity of the online ordering system for the public.
To help ease pressure on pharmacy teams in what is the busiest operational time of the year for you, we have reduced the data collection requirement until 9 January (inclusive), returning to the original operating procedure from 10 January. We will continue to monitor the demand through community pharmacies and consider any need to extend beyond the current agreement. We have provided updated data requirements and instructions on the recording process and this has been communicated to your teams through Community Pharmacy Scotland – details can be found at LFD Collect Service – Process Simplified — Community Pharmacy Scotland (cps.scot). For the period this means pharmacies only have to log the batch number of boxes distributed. This is also outlined in the attached SOP on page 6, point 3Ad.
We would encourage you to continue placing daily orders. This will ensure sufficient stock availability across the network. We would also encourage you to place the attached posters in your display windows to show that your pharmacy is participating in Pharmacy Collect. Colleagues at Community Pharmacy Scotland have also provided posters that can be displayed to show when you are in or out of stock to help minimise unnecessary footfall - Resource: LFD Test Kit Out of Stock Poster — Community Pharmacy Scotland (cps.scot).
Importantly, LFD test kits are available to everyone and do not require a prescription or the need to register for any form of community pharmacy services. It is also essential when distributing LFD test kits that we remind people that those who test positive should self-isolate and book a PCR test: around one in three people who have COVID-19 have no symptoms, and so can pass the virus to others without knowing. Evidence suggests lateral flow tests are as effective at identifying COVID-19 Omicron cases as they are for Delta cases.
By supporting the people of Scotland to undertake these tests regularly and especially before social gatherings, we can significantly reduce the risk of inadvertently passing the virus onto others. It is important to note that lateral flow tests are for people with no symptoms. The key cardinal symptoms of COVID-19 are a high temperature or fever, a new continuous cough or a loss of or change in sense of smell or taste.
Thank you for your ongoing support and we wish you a happy Christmas and New Year.
Best wishes,
Scottish Government
Pharmacy and Medicines Division
Directorate for Chief Medical Officer
Testing and Contact Tracing Policy Division
COVID Public Health Directorate
Explore how Scotland’s Future Trends report highlights the role of community pharmacy in prevention, public health, and early intervention.
We have taken a stand along with our primary care colleagues in Scotland to address the looming financial burden that is the hike in employers' National Insurance (NI) contributions announced by the UK Government last month.
Our colleagues at Scottish Government have asked us to share the 'Keep Antibiotics Working' Campaign, which aims to promote safe and sustainable antibiotics use ahead of this year's World Antimicrobial Awareness Week 2024.
Our colleagues at Scottish Government, in collaboration with COSLA have launched the ‘Rethink Dementia’ Campaign on Wednesday, 4th September 2024. The campaign encourages people to 'Rethink Dementia' as evidence shows social contact can help alleviate some symptoms commonly associated with dementia and help them stay well for longer.
Our colleagues at Scottish Government, in collaboration with COSLA have announced an upcoming launch of the ‘Rethink Dementia’ Campaign. The campaign will launch the 4th September 2024.
The Scottish Government have enacted an early release from prison scheme for low-risk offenders in a bid to ease overcrowding.
Our colleagues at the Scottish Government have asked us to disseminate the following information to pharmacy teams:
The Chief Pharmaceutical Officer for Scotland has written a letter of thanks to CP teams across Scotland
As we approach the festive period, we wanted to thank pharmacy teams for your hard work in the recent period of high demand. The community pharmacy network is a vital part of our public health response to COVID-19
The Scottish Government has now published the National Guidance for Child Protection in Scotland 2021 with a suite of accompanying documents:
Following the successful launch of the service, this circular will clarify the requirements for and the importance of reporting supply of kits to ensure proper remuneration for their distribution.
Feeling anxious about restrictions being lifted? The National Wellbeing Hub has developed new resources aimed at health and social care workers in response to reports of increased levels of anxiety
At CPS, we carry out activities to raise the profile of community pharmacy so that we can showcase the amazing work you and your teams do each and every day in support of your local population.
Circular PCA(P)(2021)10 advises NHS Boards of the procedures for community pharmacists who are qualified independent prescribers (IPs) to obtain NHS prescription stationery for use when providing the NHS Pharmacy First Plus service in community pharmacies.
The Scottish Government have released circular PCA(P)(2021)09 which advises of changes to the Drug Tariff with respect to remuneration arrangements to regulate the delivery of the remuneration Global Sum for 2020/21.
The Scottish Government has just today released a circular detailing a funded Pharmacy Collect service through which the public can access Lateral Flow test Devices (LFDs).
Circular PCA(P)(2021)07 advises that Patient Group Directions (PGDs) supporting two further common clinical conditions will be added to the NHS Pharmacy First Scotland service.
We are pleased to welcome a new team as part of the Health portfolio of Scottish Government (see below).
Circular PCA(P) (2021) 1 set out the arrangements for a time-limited medicines delivery service to be deployed by the Community Pharmacy Network to support winter pressures, NHS remobilisation and our National Strategic Framework during the COVID-19 outbreak.
This circular sets out to community pharmacy contractors and NHS Boards the details of the community pharmacy funding arrangement 2021-22. This forms part of the 3 year settlement introduced in April 2020.
This Circular provides an update To advise of a serious shortage protocol in place for levothyroxine 12.5 microgram tablets.
This Circular encloses Directions and a service specification for the Medicines: Care and Review service.
This letter advises NHS Boards and Practitioner Services of the arrangements for the NHS payment disbursement to persons working within an independent service provider setting, announced on 30 November 2020
This circular sets out the arrangements for a new time limited medicines delivery service to be deployed by the Community Pharmacy Network to support winter pressures, NHS remobilisation and our National Strategic Framework during the COVID-19 outbreak.
Details of Scotland’s 2025 Gonorrhoea Vaccination Programme using 4CMenB (Bexsero®) for high-risk groups, including eligibility, delivery model, vaccine schedule, and clinical guidance.